- Home
- HLT vs TAK Comparison
HLT vs TAK Comparison
Compare HLT & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLT
- TAK
- Stock Information
- Founded
- HLT 1919
- TAK 1781
- Country
- HLT United States
- TAK Japan
- Employees
- HLT N/A
- TAK N/A
- Industry
- HLT Hotels/Resorts
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- HLT Consumer Discretionary
- TAK Health Care
- Exchange
- HLT Nasdaq
- TAK Nasdaq
- Market Cap
- HLT 58.8B
- TAK 47.3B
- IPO Year
- HLT 2013
- TAK N/A
- Fundamental
- Price
- HLT $271.26
- TAK $15.08
- Analyst Decision
- HLT Buy
- TAK
- Analyst Count
- HLT 16
- TAK 0
- Target Price
- HLT $264.07
- TAK N/A
- AVG Volume (30 Days)
- HLT 1.3M
- TAK 3.1M
- Earning Date
- HLT 10-22-2025
- TAK 10-30-2025
- Dividend Yield
- HLT 0.22%
- TAK 3.60%
- EPS Growth
- HLT 38.11
- TAK N/A
- EPS
- HLT 6.51
- TAK 0.59
- Revenue
- HLT $4,827,000,000.00
- TAK $31,053,301,865.00
- Revenue This Year
- HLT $7.17
- TAK $0.40
- Revenue Next Year
- HLT $7.86
- TAK $0.83
- P/E Ratio
- HLT $41.85
- TAK $25.50
- Revenue Growth
- HLT 4.43
- TAK 1.52
- 52 Week Low
- HLT $196.04
- TAK $12.80
- 52 Week High
- HLT $279.81
- TAK $15.69
- Technical
- Relative Strength Index (RSI)
- HLT 47.94
- TAK 50.98
- Support Level
- HLT $271.61
- TAK $14.87
- Resistance Level
- HLT $278.78
- TAK $15.38
- Average True Range (ATR)
- HLT 4.54
- TAK 0.18
- MACD
- HLT -0.53
- TAK -0.02
- Stochastic Oscillator
- HLT 10.75
- TAK 32.97
About HLT Hilton Worldwide Holdings Inc.
Hilton Worldwide Holdings operates more than 1.2 million rooms across its more than 20 brands serving the premium economy through luxury segments. Hampton and Hilton are the two largest brands, representing 27% and 18%, respectively, of the company's total rooms, as of Dec. 31, 2024. Recent brands launched over the last few years include Home2, Curio, Canopy, Spark, Tru, Tempo, and LivSmart, as well as a partnership with Small Luxury Hotels of the World and acquisitions of NoMad and Graduate Hotels. Managed and franchised hotels represent the vast majority of adjusted EBITDA, predominantly from the Americas.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.